People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Biotechnology, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Optofluidics, Inc. | — | Biotechnology | Series A | $19.4M | $96.7M | 2020 |
| Bainbridge Health, Inc. | — | Healthtech | Seed | $9.3M | $10.9M | 2022 |
| Keriton, Inc. | — | Other Health Care | Seed | $2.2M | $11.0M | 2018 |
Shahram Hejazi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shahram Hejazi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Snider | 1 | 7 |
| Thomas Lynch | 1 | 7 |
| Sean O'Neill | 1 | 5 |
| Joseph Keegan | 1 | 4 |
| Chad Souvignier | 1 | 4 |
| Casey McGlynn | 1 | 3 |
| Thomas Todorow | 1 | 2 |
| Patrick Fitzgerald | 1 | 2 |
| Steven Powell | 1 | 2 |
| Robert Wicke | 1 | 2 |
| ROBERT HART | 1 | 2 |
| Barbara Schilberg | 1 | 2 |
| Richard Mager | 1 | 1 |
| Vidur Shailendra Bhatnagar | 1 | 1 |
| Rick Gordon | 1 | 1 |
| Joseph Kaupp | 1 | 1 |
| Sam Wilson | 1 | 1 |
| Amy Gallagher | 1 | 1 |
| Bernardo Cordovez | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.